The Korea Brain Research Institute (headed by Suh Pann-ghill) announced on July 24 the discovery that an increase in amyloid-beta in the brain alters cholesterol biosynthesis, which was found by Dr. Cheon Mookyung of KBRI through RNA-seq analysis data (omics) using AI.
The research results were published in PLOS Computational Biology, an international academic journal in the field of computational biology.
Amyloid-beta is known as a protein that causes Alzheimer’s disease (AD). In a normal brain, if it accumulates excessively, it is removed by microglia, etc. Cholesterol must also be kept at a certain level within the blood to…